VF
RCUS icon

Virtu Financial’s Arcus Biosciences RCUS Stock Holding History

Virtu Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,768
Closed -$211K – 2131
2026
Q1 		$211K Buy
+9,768
New +$211K 0.01% 1004
2021
Q2 		– Sell
-24,321
Closed -$683K – 1981
2021
Q1 		$683K Buy
+24,321
New +$846K 0.05% 369

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Virtu Financial's RCUS Position: Q2 2026 in Review

Virtu Financial sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 9,768 shares — an estimated $211K sold.

Virtu Financial first reported a position in RCUS in Q1 2021 and held it in 2 quarters. The position peaked at $683K in Q1 2021. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Virtu Financial reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 9,768 Arcus Biosciences shares in Q2 2026, an estimated $211K.
  • Virtu Financial first reported a position in Arcus Biosciences in Q1 2021 and held it in 2 quarters.
  • Virtu Financial's Arcus Biosciences position peaked at $683K in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.